GLP-1 (glucagon-like peptide-1) medications were originally developed to treat Type 2 diabetes, but researchers discovered something remarkable: people were also losing significant amounts of weight
Its a topic that can easily become confusing, especially because the FDAs protein requirements are geared toward helping people avoid a protein deficiency as opposed to optimizing their body composition which is what you want to be doing, especially during weight lose while using semaglutide
Yang L, He QS, Corscadden K, Udenigwe CC
A recent short-term cost-effectiveness analysis conducted in the United States revealed that subcutaneous Tirzepatide offers better cost-effectiveness for weight loss compared to subcutaneous Semaglutide
The term BPC-157 5mg refers only to a quantity label used for research vial identification
Also includes sorbitol (E420)